| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aging with HIV in sub-Saharan Africa
|
Sherwood-Martin, Hollie
|
|
|
23 |
11 |
p. 1232
|
artikel
|
| 2 |
A new agenda to control tuberculosis
|
The Lancet Infectious Diseases,
|
|
|
23 |
11 |
p. 1207
|
artikel
|
| 3 |
Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86
|
Yang, Sijie
|
|
|
23 |
11 |
p. e457-e459
|
artikel
|
| 4 |
A patient with secondary syphilis following incomplete treatment of primary infection
|
Lorenz, Zachary
|
|
|
23 |
11 |
p. e497-e504
|
artikel
|
| 5 |
Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study
|
Nakakubo, Sho
|
|
|
23 |
11 |
p. 1244-1256
|
artikel
|
| 6 |
A step forward for Plasmodium falciparum malaria transmission-blocking vaccines
|
Beeson, James G
|
|
|
23 |
11 |
p. 1210-1212
|
artikel
|
| 7 |
Biosimilar second-generation human papillomavirus vaccines
|
Arroyo Mühr, Laila Sara
|
|
|
23 |
11 |
p. 1215-1216
|
artikel
|
| 8 |
Communicable diseases in northwest Syria in the context of protracted armed conflict and earthquakes
|
Tarnas, Maia C
|
|
|
23 |
11 |
p. e477-e481
|
artikel
|
| 9 |
Concerns over stable artemisinin resistance in Uganda
|
Triunfol, Marcia
|
|
|
23 |
11 |
p. e470
|
artikel
|
| 10 |
Correction to Lancet Infect Dis 2023; 23: e397–98
|
|
|
|
23 |
11 |
p. e467
|
artikel
|
| 11 |
Correction to Lancet Infect Dis 2023; published online Aug 21. https://doi.org/10.1016/S1473-3099(23)00393-6
|
|
|
|
23 |
11 |
p. e467
|
artikel
|
| 12 |
Correction to Lancet Infect Dis 2023; published online Sept 8. https://doi.org/10.1016/S1473-3099(23)00372-9
|
|
|
|
23 |
11 |
p. e467
|
artikel
|
| 13 |
Daniel Bausch—linking tropical medicine to human rights
|
Samarasekera, Udani
|
|
|
23 |
11 |
p. 1228
|
artikel
|
| 14 |
Developing the EAVE III platform for future health crises
|
Simpson, Colin R
|
|
|
23 |
11 |
p. 1223-1225
|
artikel
|
| 15 |
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study
|
Kirsebom, Freja Cordelia Møller
|
|
|
23 |
11 |
p. 1235-1243
|
artikel
|
| 16 |
Effectiveness of monovalent and bivalent COVID-19 vaccines
|
Cerqueira-Silva, Thiago
|
|
|
23 |
11 |
p. 1208-1209
|
artikel
|
| 17 |
Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study
|
Lin, Dan-Yu
|
|
|
23 |
11 |
p. 1257-1265
|
artikel
|
| 18 |
Election of Regional Director for the Western Pacific
|
Balakrishnan, Vijay Shankar
|
|
|
23 |
11 |
p. e468
|
artikel
|
| 19 |
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial
|
Zhu, Feng-Cai
|
|
|
23 |
11 |
p. 1313-1322
|
artikel
|
| 20 |
Infectious diseases surveillance update
|
Zwizwai, Ruth
|
|
|
23 |
11 |
p. e475
|
artikel
|
| 21 |
John Schieffelin—fighting viral haemorragic fevers
|
Kazi, Farooq
|
|
|
23 |
11 |
p. 1229
|
artikel
|
| 22 |
Kamran Rafiq
|
Balakrishnan, Vijay Shankar
|
|
|
23 |
11 |
p. 1227
|
artikel
|
| 23 |
Main autopsy findings of visceral involvement by fatal mpox in patients with AIDS: necrotising nodular pneumonia, nodular ulcerative colitis, and diffuse vasculopathy
|
Duarte-Neto, Amaro Nunes
|
|
|
23 |
11 |
p. 1218-1222
|
artikel
|
| 24 |
Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial
|
Sagara, Issaka
|
|
|
23 |
11 |
p. 1266-1279
|
artikel
|
| 25 |
Mary-Louise McLaws
|
Bagcchi, Sanjeet
|
|
|
23 |
11 |
p. 1226
|
artikel
|
| 26 |
Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study
|
Aiken, Alexander M
|
|
|
23 |
11 |
p. 1280-1290
|
artikel
|
| 27 |
Mpox breakthrough infections: concerns and actions
|
Taha, Amira Mohamed
|
|
|
23 |
11 |
p. 1216-1218
|
artikel
|
| 28 |
Mpox neutralising antibodies at 6 months from mpox infection or MVA-BN vaccination: a comparative analysis
|
Moschetta, Nicolò
|
|
|
23 |
11 |
p. e455-e456
|
artikel
|
| 29 |
Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study
|
Cohn, Hallie
|
|
|
23 |
11 |
p. 1302-1312
|
artikel
|
| 30 |
New licensing agreements for COVID-19
|
Jesudason, Timothy
|
|
|
23 |
11 |
p. e471
|
artikel
|
| 31 |
Nipah virus: an ever-present threat
|
Burki, Talha
|
|
|
23 |
11 |
p. e473-e474
|
artikel
|
| 32 |
Pertussis cases rise in Denmark
|
Bagcchi, Sanjeet
|
|
|
23 |
11 |
p. e469
|
artikel
|
| 33 |
Pneumococcal serosurveillance: one piece of the puzzle
|
Licciardi, Paul Vincent
|
|
|
23 |
11 |
p. 1212-1214
|
artikel
|
| 34 |
Population immunity to pneumococcal serotypes in Kilifi, Kenya, before and 6 years after the introduction of PCV10 with a catch-up campaign: an observational study of cross-sectional serosurveys
|
Gallagher, Katherine E
|
|
|
23 |
11 |
p. 1291-1301
|
artikel
|
| 35 |
Progress in the evaluation of modified vaccinia Ankara vaccine against mpox
|
Mazzotta, Valentina
|
|
|
23 |
11 |
p. 1214-1215
|
artikel
|
| 36 |
Research in brief
|
Devi, Sharmila
|
|
|
23 |
11 |
p. e476
|
artikel
|
| 37 |
Second stage human African Trypanosomiasis with Trypanosoma brucei rhodesiense treated with fexinidazole
|
Helleberg, Barbara Brask
|
|
|
23 |
11 |
p. e505
|
artikel
|
| 38 |
Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responses
|
Sheward, Daniel J
|
|
|
23 |
11 |
p. e462-e463
|
artikel
|
| 39 |
The cancer of women
|
Sherwood-Martin, Hollie
|
|
|
23 |
11 |
p. 1233
|
artikel
|
| 40 |
The challenges in the monitoring of infectious diseases after the earthquake in Türkiye in 2023
|
Ergönül, Önder
|
|
|
23 |
11 |
p. e482-e488
|
artikel
|
| 41 |
The fight against the deadly rise of anti-science
|
Mishra, Shiva Raj
|
|
|
23 |
11 |
p. 1234
|
artikel
|
| 42 |
The future of COVID-19 surveillance in Japan
|
Tsuzuki, Shinya
|
|
|
23 |
11 |
p. 1209-1210
|
artikel
|
| 43 |
The importance of getting the ethics right in a pandemic treaty
|
Schaefer, G Owen
|
|
|
23 |
11 |
p. e489-e496
|
artikel
|
| 44 |
The legacy of the Black angels
|
Furin, Jennifer
|
|
|
23 |
11 |
p. 1231
|
artikel
|
| 45 |
The TB Vaccine Accelerator Council: harnessing the power of vaccines to end the tuberculosis epidemic
|
Ghebreyesus, Tedros Adhanom
|
|
|
23 |
11 |
p. 1222-1223
|
artikel
|
| 46 |
14th Neglected Tropical Disease NGO Network conference
|
Jesudason, Timothy
|
|
|
23 |
11 |
p. e472
|
artikel
|
| 47 |
Tracing the new SARS-CoV-2 variant BA.2.86 in the community through wastewater surveillance in Bangkok, Thailand
|
Wannigama, Dhammika Leshan
|
|
|
23 |
11 |
p. e464-e466
|
artikel
|
| 48 |
Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant
|
Uriu, Keiya
|
|
|
23 |
11 |
p. e460-e461
|
artikel
|
| 49 |
William Fischer—advancing bedside care during outbreaks
|
Kirby, Tony
|
|
|
23 |
11 |
p. 1230
|
artikel
|
Tijdschrift beschrijving